Financial Survey: Concord Medical Services Holdings Limited (CCM) versus Chemed Corp. (CHE)
Concord Medical Services Holdings Limited (NYSE: CCM) and Chemed Corp. (NYSE:CHE) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, risk, earnings, analyst recommendations and profitability.
This table compares Concord Medical Services Holdings Limited and Chemed Corp.’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Concord Medical Services Holdings Limited||N/A||N/A||N/A|
This is a breakdown of current ratings and recommmendations for Concord Medical Services Holdings Limited and Chemed Corp., as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Concord Medical Services Holdings Limited||0||0||0||0||N/A|
Chemed Corp. has a consensus price target of $214.50, suggesting a potential upside of 7.42%. Given Chemed Corp.’s higher probable upside, analysts clearly believe Chemed Corp. is more favorable than Concord Medical Services Holdings Limited.
Institutional & Insider Ownership
12.6% of Concord Medical Services Holdings Limited shares are held by institutional investors. Comparatively, 97.0% of Chemed Corp. shares are held by institutional investors. 46.5% of Concord Medical Services Holdings Limited shares are held by company insiders. Comparatively, 5.3% of Chemed Corp. shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Valuation & Earnings
This table compares Concord Medical Services Holdings Limited and Chemed Corp.’s gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|Concord Medical Services Holdings Limited||$62.26 million||2.45||-$8.29 million||N/A||N/A|
|Chemed Corp.||$1.62 billion||1.97||$226.52 million||$3.99||50.05|
Chemed Corp. has higher revenue and earnings than Concord Medical Services Holdings Limited.
Chemed Corp. pays an annual dividend of $1.12 per share and has a dividend yield of 0.6%. Concord Medical Services Holdings Limited does not pay a dividend. Chemed Corp. pays out 28.1% of its earnings in the form of a dividend. Chemed Corp. has increased its dividend for 8 consecutive years.
Risk and Volatility
Concord Medical Services Holdings Limited has a beta of 0.73, suggesting that its share price is 27% less volatile than the S&P 500. Comparatively, Chemed Corp. has a beta of 1.13, suggesting that its share price is 13% more volatile than the S&P 500.
Chemed Corp. beats Concord Medical Services Holdings Limited on 11 of the 14 factors compared between the two stocks.
Concord Medical Services Holdings Limited Company Profile
Concord Medical Services Holdings Limited is engaged in the leasing of radiotherapy and diagnostic imaging equipment, the provision of management services to hospitals. The Company is also engaged in hospital operations. The Company’s segments are network and premium cancer hospital. The Company operates a network of radiotherapy and diagnostic imaging centers in China. Its network consists of approximately 130 cooperative centers based in over 70 hospitals, spanning approximately 60 cities across 25 provinces and administrative regions in China. Its network includes approximately 60 radiotherapy centers and over 60 diagnostic imaging centers and approximately seven centers. The Company’s cooperative centers are equipped with a primary unit of medical equipment, such as a linear accelerator, head gamma knife system, body gamma knife system, positron emission tomography-computed tomography (PET-CT) scanner or magnetic resonance imaging (MRI) scanner.
Chemed Corp. Company Profile
Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. VITAS is the provider of hospice services in an industry dominated primarily by small, non-profit, community-based hospices. VITAS provides hospice care to Medicare beneficiaries participating in these managed care programs. A portion of its VITAS business is operated in the state of Florida. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration and other related services to both residential and commercial customers.
Receive News & Ratings for Concord Medical Services Holdings Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concord Medical Services Holdings Limited and related companies with MarketBeat.com's FREE daily email newsletter.